T he redox cofactor nicotinamide adenine dinucleotide (NAD) was recently reported to be covalently linked to the 5′ end of bacterial RNA 1 primarily on a subset of small regulatory RNAs in a cap-like manner 2 . Addition of the NAD cap to RNAs appears to occur during transcription initiation 3 . The transcriptional incorporation of NAD at the 5′ end is supported by in vitro incorporation of NAD as a 'non-canonical initiating nucleotide' by bacterial RNA polymerase that can integrate NAD as the first transcribed nucleotide in place of ATP [3] [4] [5] . More recently, NAD-capped RNAs were also confirmed in eukaryotes with their identification in Saccharomyces cerevisiae 6 and mammalian cells 7 . These findings demonstrate the broad distribution of NAD caps in diverse organisms.
The bacterial Nudix (nucleoside diphosphate linked to another moiety X) hydrolase NudC, initially described as an NAD/H pyrophosphohydrolase 8 , can remove the NAD cap by hydrolyzing the diphosphate linkage to produce nicotinamide mononucleotide (NMN) and 5′ monophosphate RNA 2 . Bacterial strains lacking NudC exhibit an increase in steady state levels of NAD-capped RNAs, interpreted to function as a stability element in bacteria 2, 3 implicating NudC as a deNADding enzyme that removes the protective NAD cap to promote decay. The NAD cap has been reported to protect RNA from 5′ end degradation by the bacterial RppH Nudix protein and RNaseE nucleases in vitro 2 . RppH contributes to the generation of monophosphorylated 5′ end transcripts 9 that can further be subjected to RNaseE directed decay 10 . The mammalian Nudix protein Nudt12 is a close homolog of bacterial NudC 11, 12 . It was identified as an NAD/H diphosphatase with a substrate preference for the reduced nicotinamide dinucleotide 13 . Although Nudt12 was initially shown to localize to peroxisomes when fused to a C-terminal green fluorescent protein 13 , immunocytochemistry reveals it is also cytoplasmic in at least kidney cells 14 indicating a cytoplasmic function. The mammalian non-canonical decapping enzyme, DXO 15 possesses deNADding activity by removing the entire NAD moiety from the 5′ end of an NAD-capped RNA in cells 7 . In contrast to the canonical N7 methylguanosine (m 7 G) cap, the NAD cap promotes, rather than prevents, RNA decay in mammalian cells 7 . Removal of DXO from mammalian cells allowed detection of NAD-capped intronic small nucleolar RNAs (snoRNAs), suggesting that NAD caps can also be added to 5′ processed termini, in addition to transcriptional incorporation at the 5′ end, indicating the existence of an NAD capping mechanism 7, 16 . In this report, we provide several lines of evidence demonstrating that, in addition to DXO, Nudt12 is a deNADding enzyme that targets RNAs distinct from those subjected to DXO deNADding. We further demonstrate that both enzymes are functional in cells and their removal from cells increases the level of NAD-capped RNA. Moreover, NAD capping can be altered by cellular exposure to stress indicating NAD-cap levels can be dynamic and vary with cellular metabolic load.
Results

Mammalian Nudt12 deNADs NAD-capped RNA in vitro.
Eukaryotic cells possess multiple decapping enzymes that function on distinct messenger RNA subsets 17 . We reasoned that, analogous to decapping proteins, the recently described DXO/Rai1 family of deNADding enzymes 7, 18 may also be just one of multiple deNADding enzymes that each regulate a subset of RNAs. Two Nudix hydrolase proteins that can hydrolyze free NAD, Nudt12 and Nudt13 (refs. 13, 19 ) were initially pursued. To assess the potential deNADding activity of mouse Nudt12 and Nudt13, both recombinant proteins were incubated either with products were further treated with nuclease P1, which cleaves all phosphodiester bonds within an RNA and releases the terminal labeled p * A (Fig. 1b) . Nudt12 but not Nudt13 possessed NAD-cap deNADding activity in vitro under the conditions and protein concentrations used (Fig. 1b) , suggesting not all NAD hydrolyzing enzymes contain comparable RNA deNADding activity. Consistent with this premise, enhancer of mRNA decapping 3 (Edc3) protein, which is an NAD(H)-binding protein with potential hydrolytic activity on free NAD(H) 20 , also failed to exhibit deNADding activity ( Supplementary Fig. 1 ).
The cleavage activity of Nudt12 on NAD-capped RNA substrate is between the diphosphate linkage and similar to the activity observed with NudC 2 yet distinct from that of DXO, which removes the intact NAD by cleaving the phosphodiester linkage following the adenosine residue 7 ( Supplementary Fig. 2 ). A comparison of Nudt12 decapping activity on m 7 G-capped RNA 21 to that of its deNADding activity revealed a greater level of deNADding relative to decapping (Fig. 1c) . Nudt12 deNADding activity was compromised by a catalytically inactive mutant harboring glutamine substitutions for two glutamic acid metal coordination residues (Fig. 1c) that is known to abolish Nudt12 decapping activity 21 , demonstrating that the decapping and deNADding activities of Nudt12 use the same active site.
Distinct classes of deNADding enzymes.
To determine the relative activities of Nudt12 and NudC, their hydrolysis activity on NAD, NAD-capped RNA and m 7 G-capped RNA were tested. Under these in vitro parameters, both enzymes possessed activity on free NAD, NAD-capped RNA and RNA capped with m 7 G (Fig. 2a) . The bacterial RppH protein, which was included as a negative control, lacked hydrolytic activity on free NAD as expected (Fig. 2a) , but contained robust deNADding activity on NAD-capped RNA (Fig. 2a , middle panel). RppH deNADding activity was compromised with a catalytic inactive 21, 22 mutant (Fig. 2b ) demonstrating the observed deNADding activity is an intrinsic function of wild-type RppH. Collectively, these findings indicate there are at least three classes of deNADding enzymes (Supplementary Table 1 ). The first is the DXO family of proteins that remove the entire NAD from the 5′ end of an RNA 7 ( Supplementary Fig. 2 ). The second is represented by NudC and Nudt12 that cleaves within the pyrophosphate of both NAD and NAD-capped RNA. The third class contains RppH, which does not cleave NAD, but does cleave NAD-capped RNA. The result with RppH is reminiscent of canonical Nudix m 7 G decapping enzymes that need to bind the RNA body to cleave the cap and contain minimal activity on cap structure alone 21, 23 .
Structural insights into Nudt12 deNADding.
We determined the crystal structure of the catalytic domain of mouse Nudt12 (residues 126-462) in complex with AMP and three Mg 2+ ions at 1.6 Å resolution (Supplementary Table 2 ). Nudt12 contains an Ankyrin repeat domain in the N-terminal region ( Supplementary Fig. 3a) , which is required for RNA deNADding activity but dispensable for NAD hydrolysis ( Supplementary Fig. 3b ).
The Nudt12 catalytic domain consists of an N-terminal subdomain (NTD, residues 126-282), a zinc-binding motif (residues 283-318) and a C-terminal sub-domain (CTD, residues 319-462) ( Supplementary Fig. 3a) . The conserved Nudix sequence elements are located in the CTD, although the NTD also has the Nudix fold. The catalytic domain forms a dimer with an extensive interface, involving contributions from all three sub-domains (Fig. 3a) . The two monomers have essentially the same conformation, with root mean squared distance of 0.46 Å for 303 aligned Cα atoms ( Supplementary Fig. 3c ). The catalytic domain shares 29% amino acid sequence identity with E. coli NudC. While the overall structure of Nudt12 is similar to that of NudC 24 , there are also substantial differences between them, especially for the NTD ( Supplementary  Fig. 3c,d ). The root mean squared distance in Cα atoms is 2.0 Å for 226 aligned residues between the two proteins.
While we included NAD during crystallization, clear electron density was observed for AMP on the basis of the crystallographic analysis (Fig. 3b) , consistent with the catalytic activity of Nudt12 ( Supplementary Fig. 3c ). AMP is primarily bound to the CTD of one protomer (Fig. 3a) . The adenine base is in the syn configuration, π-stacked with the side chain of Phe356 on one face and on the other face with that of Tyr318 in the other protomer (Fig. 3b) .
The phosphate group of AMP is involved in a large network of interactions with Nudt12, mediated through three Mg 2+ ions (named Mg1, Mg2 and Mg3) (Fig. 3b) . One of the terminal oxygen atoms of the phosphate is a bridging ligand to Mg1 and Mg2, while a second terminal oxygen atom is coordinated to Mg3. Three Glu residues in the Nudix motif are ligands of the Mg 2+ ions, including Glu370 (bidentate interactions with Mg2 and Mg3), Glu374 (coordinated to Mg1), and Glu415 (bidentate interactions with Mg1 and in which the line represents RNA, and addition of Nuclease P1 to cleave all phosphodiester bonds is denoted by Nuc P1. Reaction products of NAD-capped RNA were resolved as in a, and + indicates further treatment with Nuclease P1. A schematic of the NAD-capped RNA substrate and hydrolyzed products is shown. Labeling is as described in a above. c, In vitro decapping/deNADding assays with mouse Nudt12 protein and indicated 32 P-cap-labeled substrates. Catalytically inactive double-mutant Nudt12E373Q/E374Q (N12E/Q) lacks deNADding activity. Labeling is as described in a.
Mg2). Each Mg
2+ ion is coordinated octahedrally and seven water molecules or hydroxide ions complete the coordination spheres, one of which is a bridging ligand between Mg2 and Mg3 (Fig. 3b) .
The binding mode of AMP in the current structure has significant differences compared to that of the AMP portion of NAD in the complex with NudC 11, 24 (Fig. 3c) . Probably due to the absence of metal ions in the NudC complex, the phosphate group is pushed away from the Glu side chains in the active site and the distance between the phosphorus atoms in the two structures is 5.4 Å (Fig. 3c) . In addition, the adenine base is in the anti-configuration in one NudC complex structure 24 and both anti-and syn-configurations in the other NudC complex structure 11 . On the other hand, the NMN portion of NAD in NudC is located near the AMP in the current structure (Fig. 3d) and a model for the binding mode of NAD to Nudt12 could be built based on this (Fig. 3d) .
The model of the NAD complex provides clear molecular insights into the deNADing mechanism. The bridging ligand between Mg2 and Mg3 is located directly beneath the phosphate group of AMP, with a distance of 3.0 Å to the phosphorus atom (Fig. 3d) . It initiates the deNADding reaction by attacking the phosphorus atom. There does not appear to be a general acid from the protein, in Nudt12 or NudC, that can stabilize the oxyanion of the leaving group and this role might be served by a solvent molecule that becomes bound in the presence of NAD.
Mammalian Nudt12 is a deNADding enzyme in cells. To assess whether Nudt12 contributes to the expression of endogenous NAD-capped RNA in cells, we used NAD-cap detection and quantitation (NAD-capQ 18 ) approach that detects NAD caps en masse. NAD-capQ combines the enzymatic properties of nuclease P1 to release intact NAD from the 5′ end of NAD-capped cellular RNA, with a colorimetric NAD quantitation to detect the released NAD ( Supplementary Fig. 4a ). Following demonstration that both human and mouse Nudt12 possess comparable deNADding activity ( Supplementary Fig. 4b ), a collection of CRISPR/Cas9n directed individual or double knockout human HEK293T cell lines comprised of a pool of three monoclonal knockout cell lines in the Nudt12 gene (N12-KO), were generated and used (Fig. 4a) . Consistent with Nudt12 functioning as a deNADding enzyme in cells, a 1.5-fold increase in total NAD-capped RNA was detected by NAD-capQ in cells devoid of Nudt12 compared to the control knockout (Con-KO; Fig. 4b ). RNA from a pool of monoclonal cells containing homozygous disruptions in the DXO gene DXO-KO 7 ); revealed a similar 1.5-fold increase in cellular NAD caps (Fig. 4b) . A pool of monoclonal lines harboring homozygous disruption of both the Nudt12 and DXO genes (N12:DXO-KO; Fig. 4a ) resulted in 2.7-fold higher levels of NAD caps (Fig. 4b) .
To test whether Nudt12 can modulate the stability of NADcapped RNA in cells, 32 P uniformly labeled RNA transcripts, containing either NAD or m 7 G at the 5′ end and 16 consecutive guanosine nucleosides (G 16 ) at the 3′ end to minimize 3′ end decay 25 , were transfected into Con-KO or N12-KO cells. RNA was collected at various times up to 4 h post transfection, resolved and detected. As shown in Fig. 4c , NAD-capped transcripts were more stable in N12-KO than Con-KO cells (t ½ = 4.1 h versus 2.2 h). In contrast, m 7 G-capped RNA showed similar half-lives in both cell line backgrounds (Fig. 4d) , which is consistent with previous studies with a knockout of a single decapping enzyme 15, 26 . We conclude Nudt12 can modulate the stability of NAD-capped RNAs transfected into HEK293T cells. Collectively, these data demonstrate that in addition to DXO 7 , Nudt12 is also a deNADding enzyme that can regulate the stability of NAD-capped RNAs in cells and each deNADding enzyme appears to function on distinct NAD-capped RNAs.
Nudt12 preferentially deNADs a subset of mRNAs. To directly determine whether Nudt12 contributes to the expression of specific NAD-capped RNAs in cells, we used the NAD-captureSeq approach, which was successfully used to isolate NAD-capped RNAs in bacteria 2 , yeast 6 and human 7 cells. Briefly, NAD-capped RNAs are identified by the reaction of the 5′ end NAD with adenosine diphosphate ribosylcyclase to generate an alkyne moiety amendable to click chemistry selective covalent incorporation of biotin and purification of the modified RNA with streptavidin 27 . NAD-captureSeq was carried out with RNAs from HEK293T wild-type or N12-KO cells. Selecting reference transcripts with at least a two-fold increase in N12-KO compared with wild type, at least one fragment per kilobase of transcript length per million aligned reads (FPKM) expression level in N12-KO and ≤5% false discovery rate (FDR) revealed 188 NAD-capped RNAs that were specifically enriched in the N12-KO cells (Supplementary Table 3 suggesting these are targets of Nudt12 deNADding. Subjecting the RNAs increased in Nudt12 knockout to gene ontology using high stringency (FDR ≤ 5%, ≥10 transcripts per term) revealed that the proteins they encode are in five main significantly enriched pathways, three biological process terms and two cellular compartment terms ( Supplementary Fig. 5a ). One of these relates to ribosomal RNA processing while the remaining are linked with mitochondrial metabolism or translation. While transcripts relating to rRNA processing are enriched, none of the 231 nuclear-encoded ribosomal protein gene transcripts was significantly different in N12-KO. Among the 150 nuclear-encoded mitochondrial ribosomal transcripts, ten are significantly enriched in N12-KO (listed in  Supplementary Table 3 , beginning with MRPL and MRPS), but none of the mitochondrial encoded transcripts were altered. The mRNAs enriched in N12-KO are associated primarily with respiratory function, suggesting an interaction between cell metabolism and Nud12 deNADding of NAD-capped transcripts.
A subset of the NAD-captureSeq identified RNAs consisting of five RNAs implicated in oxidative phosphorylation and seven randomly selected mRNAs were chosen for further validation (Fig. 5a ). . The AMP portion of the model is identical to the crystal structure, and the NMN portion is based on that in the NudC complex. The nucleophilic attack by the bridging ligand of Mg2 and Mg3 on the phosphate, indicated by the black arrow, initiates the deNADding reaction. The water molecule that is displaced in the NAD complex is indicated with the arrowhead (red). G-capped RNA (d) were transfected into the indicated cell lines using Lipofectamine 3000. Untransfected RNAs were degraded with micrococcal nuclease (MN), and total RNA was isolated at the times denoted following micrococcal nuclease treatment. Remaining RNA was resolved on 8% denaturing PAGE, exposed to a PhosphorImager, quantitated and plotted. All data are derived from three independent experiments, with ± s.e.m. denoted by the error bars. Linear regression was used to fit the time course data to an equation with or without the category labels (Con-KO or N12-KO). Statistical significance level was calculated by comparing these two models with oneway ANOVA (F = 25.303, d.f. = 26; ***P ≤ 0.001; Con-KO t ½ = 4.1 h, N12-KO t ½ = 2.2 h). See Supplementary Fig. 8 for extended RNA gels.
We found that 11 out of 12 NAD-capped mRNAs identified from the NAD-captureSeq to be enriched in N12-KO cells were validated by direct quantitative reverse transcription with PCR (qRT-PCR), while the non-Nudt12 target CKS2 mRNA, was not changed in N12-KO compared to wild-type cells. Seven of the confirmed genes (COX17, MRPL15, MRPS23, NDUFA4, NDUFB2, NDUFB9 and NDUFS3, highlighted in Supplementary Table 3) were found in the enriched gene ontology terms in Supplementary Fig. 5a . These data further verify Nudt12 as a deNADding enzyme in cells and suggest a role for Nudt12 in nuclear-encoded NAD-capped transcripts encoding proteins with metabolic functions.
Applying similar data analysis to NAD-capped RNAs from DXO-KO cells 7 , we found that mRNAs enriched in the absence of Nudt12 were relatively distinct from those enriched when DXO was removed (Supplementary Fig. 5b ). Out of 188 unique RefSeq mRNAs enriched in N12-KO, only 13 overlap the 67 RefSeq mRNAs enriched by DXO-KO. Previous analyses identified many more DXO-KO-regulated transcripts from the same samples 7 , probably due to the inclusion of contrasting m 7 G-capped samples in the earlier analysis, which influenced the statistical evaluation. We found groups of NAD-capped RNA uniquely targeted by each enzyme (Fig. 5b) . The hierarchical clustering of all 242 transcripts by replicate sample (Fig. 5b) indicates the distinct patterns of transcripts enriched in Nudt12 (light blue in the right color bar) or DXO (coral in the right color bar). Highlighting the enriched gene ontology terms in the left color bar, the Nudt12-enriched gene ontology terms are similarly distinct from a main DXO-KO category. Of the 175 genes enriched exclusively in N12-KO, two of the top gene ontologybiological processes are linked to mitochondrial metabolism. In contrast, the most prominent class of NAD-capped RNAs elevated in DXO-KO cells, the snoRNAs and the related small Cajal body RNAs (scaRNAs) 7 ( Fig. 5b) , were not elevated in NAD captureSeq from cells lacking Nudt12. NAD-capped mRNAs involved in oxidative phosphorylation were specifically enriched in N12-KO cells (Fig. 5) . Collectively, these analyses revealed existence of Nudt12 and DXO responsive NAD-capped RNAs in mammalian cells and a modulation of distinct subset of mRNAs by each deNADding enzyme.
Environmental stress can impact NAD capping. Changes in growth conditions or exposure to environmental stress are often accompanied by changes in cellular NAD metabolism. In human cells, cellular NAD levels increase in response to energy stresses, such as glucose deprivation 28 , fasting 29, 30 and caloric restriction 31 , indicating that the nutrient state of a cell influences NAD concentrations. To assess whether physiological changes in cellular NAD can manifest altered NAD cap levels in cells, HEK293T cells were subjected to two distinct environmental stress conditions previously shown to affect cellular NAD metabolism: heat shock 32 and glucose deprivation 28 . Cells were treated up to 4 h with a 42 °C heat shock or grown in glucose-free medium. Quantitation of NAD caps by NADcapQ revealed ~two-fold increase in cells exposed to either heat shock or glucose deprivation (Fig. 6a) . The increase is not restricted to transformed cells. A similar two-fold increase in NAD cap levels was detected in glucose deprived primary human foreskin fibroblast (HFF) cells (Fig. 6a) . The increases in NAD-capped RNA are not a consequence of increases in cellular NAD levels following stress (Fig. 6b) . A 1.4-fold increase in cellular NAD concentration was evident in HEK293T cells following heat shock, 1.1-fold increase in glucose deprivation HFF cells and a decrease in HEK293T cells subjected to glucose deprivation (Fig. 6b) .
To assess whether cellular stress contributes to changes in the expression of specific Nudt12 or DXO target NAD-capped RNAs, total NAD-capped RNAs were isolated by NAD-capture analogous to Fig. 5 . Six Nudt12 target NAD-capped transcripts validated in Fig. 5a or DXO target NAD-capped mRNAs 7 were randomly chosen and quantified. All six Nudt12 responsive NAD-capped mRNAs tested were preferentially increased after glucose deprivation but not heat shock (Fig. 6c) consistent with a role of Nudt12 in modulating mRNAs involved in cellular metabolism. In contrast, four of the six DXO responsive NAD-capped mRNAs tested increased after heat shock, but not glucose deprivation (Fig. 6c ). These observations demonstrate distinct functions for the two deNADding enzymes following different cellular stresses. The levels of Nudt12 protein remained constant (Supplementary Fig. 6 ) with heat shock or glucose deprivation indicating the increase in NAD-capped Nudt12 target mRNAs were not a function of altered Nudt12 protein concentrations and may involve a regulation of its activity following glucose deprivation. However, DXO protein levels were found to specifically decrease following heat shock ( Supplementary Fig. 6 ) consistent with the increase in DXO target NAD-capped mRNA on heat shock. Collectively, our data demonstrate NAD-capped mRNA levels are dynamic and can be influenced by cellular exposure to stress. Moreover, NAD-capped mRNA levels are selectively modulated by Nudt12 and DXO following exposure to distinct stress conditions where the contributions of Nudt12 are evident following nutrient stress and DXO following environmental stress. Fig. 5b ). For each mRNA in the heatmap, blue indicates relative enrichment and yellow indicates relative depletion, with expression normalized for each mRNA across all samples to indicate relative differences. Individual replicate samples from each group are indicated by a trailing number ('_0', '_1', and so on). WT, wild type.
Discussion
Regulation of mRNA stability is an important post-transcriptional process that impacts eukaryotic gene expression. The presence of NAD caps in organisms ranging from E. coli to humans demonstrates the evolutionary conservation of the non-canonical NAD cap at the 5′ end of RNA transcripts and implies a function in RNA metabolism 16 . In this report, we demonstrate that, similar to the presence of multiple m 7 G cap decapping enzymes in cells 17 , mammalian cells also use Nudt12 as a deNADding enzyme. Nudt12 contains deNADding activity in vitro (Fig. 1) , in human cells (Fig. 4) and targets a specific group of mRNA for deNADding (Fig. 5) . The crystal structure of mouse Nudt12 catalytic domain (residues 126-462) defines the binding mode of the AMP product and three coordinated magnesium ions. The structure also provides detailed insights into the molecular mechanism of the deNADding reaction (Fig. 3) and its distinct hydrolysis at the pyrophosphate linkage in Nudt12 to release NMN from NAD-capped RNA compared to the phosphodiester linkage in DXO that releases an intact NAD 7 . Nudt12 is a deNADding enzyme that can promote the decay of NAD-capped RNAs in cells (Fig. 4) and it targets a subset of RNAs that are distinct from that of DXO (Fig. 5) . Cells lacking either Nudt12 or DXO protein each contained a ~1.5-fold increase in total NAD-capped cellular RNA and almost three-fold in the double N12:DXO-KO cells (Fig. 4b) indicating that Nudt12 and DXO target different classes of NAD-capped RNAs for deNADding. Specificity of deNADding enzymes was further supported by identification of responsive target mRNAs. Specific NAD-capped RNAs, including histones and nuclear-encoded mRNAs coding for mitochondrial proteins are relatively enriched in N12-KO cells (Fig. 5b, blue) while depleted in DXO-KO cells (Fig. 5b, yellow) . Conversely, NADcapped sno/scaRNAs are highly enriched in DXO-KO cells but not detected in cells lacking Nudt12.
Similar to m 7 G cap decapping enzymes 17 , deNADding enzymes also preferentially target distinct mRNA subsets within different cellular pathways. Out of the mRNAs encoding proteins in the mitochondrial electron transport chain, 14 (19%) contained NAD-capped versions that were elevated in Nudt12-KO cells (P = 1.79 × 10 -16 ; Hypergeometric distribution). These findings support a correlation between Nudt12 deNADding activity and cellular energetics and suggest NAD capping of mRNAs encoding mitochondrial oxidative phosphorylation proteins may be a means of coordinating cellular energy demand with mitochondrial output. However, how the deNADding enzymes differentiate between different RNA substrates and preferentially deNAD specific RNAs remains unknown. Whether Nudt12 and DXO use a direct mechanism analogous to Dcp2 binding of a stem loop structure 33, 34 or an indirect mechanism by protein recruitment 35, 36 remains to be determined. c, qRT-PCR analysis of a subset of Nudt12 or DXO specific NAD-capped mRNAs from HEK293T cells exposed to either 4 h GD or HS. NAD-capped RNAs isolated by the NAD-capture approach were eluted from the beads, reverse transcribed and indicated mRNAs detected with gene-specific primers. Data are presented relative to cells that were not subjected to stress conditions set to 1 (n = 3 independent NAD-capture experiments; mean ± s.e.m.; unpaired t-test; *P < 0.05; **P < 0.01, ***P < 0.001).
An unexpected outcome of our studies is that the bacterial RppH Nudix protein also possesses deNADding activity, at least in vitro (Fig. 2a) . The discrepancy with a previous report 2 is probably due to different in vitro deNADding conditions and different substrate RNAs employed in the two studies, for instance presence of guanosine in the +2 position of the RNA we used. The latter feature was recently shown to increase BsRppH deNADding activity compared to RNA variants with the other nucleosides occupying this position 37 . RppH, unlike Nudt12 and NudC possess robust deNADding activity on NAD-capped transcripts in vitro, but not capable of hydrolyzing free NAD in vitro (Fig. 2a) , thus defining at least three distinct classes of deNADding enzymes (Supplementary Table 1 ). Class I deNADding enzymes consist of the DXO family of proteins that remove an intact NAD from the 5′ end of NAD-capped RNAs 7 . Class II consists of proteins that can hydrolyze the pyrophosphate linkage of both free NAD as well as NAD at the 5′ end of an RNA and is represented by Nudt12 and NudC. Class III deNADding enzymes only function on NAD-capped RNA but not free NAD with RppH as the founding member.
Another important finding from these studies was the demonstration that environmental stress and nutrient deprivation can both lead to elevation of NAD-capped RNA. NAD levels can fluctuate along with the metabolic state of a cell that prompted us to test whether NAD-capped RNA levels are altered with stress. Although NAD-capped RNA levels increased following two different stress parameters employed, cellular NAD levels did not consistently demonstrate a similar increase (Fig. 6 ). These findings demonstrate that NAD cap levels can be modulated under stress conditions and this modulation is not necessarily a direct function of cellular NAD levels. Moreover, exposure of cells to nutrient or environmental stress differentially affects Nudt12-and DXO-targeted NADcapped mRNAs, with Nudt12 functionality apparent under glucose deprivation and DXO evident under heat shock. Collectively, alteration of NAD-capped mRNA levels may provide a physiological link between the metabolic state of a cell and its mRNA composition.
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Methods
Cell culture and generation of Nudt12 and N12:DXO CRISPR knockout cell lines. Human embryonic kidney HEK293T cells were obtained from ATCC. Cells were cultured in DMEM medium (Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (Atlanta Biologics) and antibiotics (100 units per ml penicillin and 100 µg ml −1 of streptomycin) under 5% CO 2 at 37 °C. The three different monoclonal HEK293T cell lines harboring CRISPR-Cas9n double-nick generated distinct homozygous deletions inside the DXO gene genomic region corresponding to its catalytic site have been reported previously 7 . Nudt12 knockout lines were similarly generated using CRISPR-Cas9n technology with two Nudt12-gRNAs (Supplementary Table 3 ) designed to target genomic regions of Nudt12 corresponding to the catalytic site in exon 6. Nudt12:DXO double knockout lines were generated using the Nudt12 cell line and CRISPR-Cas9n technology with two DXO-gRNAs (Supplementary Table 3 ) designed to target genomic regions of DXO corresponding to the catalytic site in exon 4. The genomic modification was screened by PCR and confirmed by sequencing and a western blot of the three mixed clones for N12-KO or N12:DXO-KO is shown in Fig. 4a .
Isolation and identification of NAD-capped RNAs. Total RNA from HEK293T, Con-KO, N12-KO, DXO-KO and N12:DXO-KO cell lines were isolated with TRIzol reagent (Thermo Fisher Scientific). NAD-capped RNAs were isolated using the NAD-RNA capture protocol 2 with minor modification. NAD-capture was carried out with 50 µg total RNA treated with 10 µl 4-pentyn-1-ol (Sigma-Aldrich) and 3 U of ADP ribosylcyclase in 100 µl reaction containing 50 mM HEPES, 5 mM In vitro transcription of NAD-capped RNAs. RNAs containing different cap structures were synthesized by in vitro transcription of plasmid ɸ2.5A-CA2-G16 containing the T7 ɸ2.5 promoter 38 that retained the first adenosine at the transcription start site. All other adenosines in the RNA were replaced by uracils to maintain only one adenosine per RNA and a G-tract of 16 guanosines (G16) was present at the 3′ end 7 . In vitro transcription was carried out at 37 o C for 90 min in 50 µl reaction containing 400 ng PCR-generated DNA template, 10 µl 5× transcription buffer, 5 µl DTT (10 mM), 5 µl BSA (10 µg µl GpppA cap analog (New England BioLabs) minus rATP in the reaction was carried out to produce 32 P uniformly labeled 5′ end N7-methylated RNA.
RNA in vitro decapping and deNADding assays. The 32 P-NAD-cap labeled or 32 P-m 7 G-capped RNAs were incubated with the indicated amount of recombinant proteins in decapping buffer containing 10 mM Tris-HCl pH 7.5, 100 mM KCl, 2 mM DTT, 2 mM MgCl 2 and 2 mM MnCl 2 as previously described 39 and incubated at 37 o C for 30 min. Reactions were stopped with 30 mM EDTA. For reactions involving Nuclease P1 treatment, reactions were first extracted with phenol followed by chloroform and 1 U of Nuclease P1 (Sigma-Aldrich) was added. The reactions were incubated at 37 o C for 30 min. Decapping products were resolved by PEI-cellulose TLC plates (Sigma-Aldrich) and developed in 0.5 M LiCl or 0.45 M (NH 4 ) 2 SO 4 in a TLC chamber at room temperature 40 . deNADding assays in Supplementary Fig. 4b were similarly carried out except, following termination of the reaction with 30 mM EDTA, the RNA were resolved by 15% denaturing polyacrylamide gel electrophoresis and dried. Reaction products were visualized with a Molecular Dynamics PhosphorImager (Storm860).
RNA in vivo decay assay. Indicated cells (8 × 10 6 ) were seeded in 100 mm plates 1 day before the experiment. Then 0.5 µg 32 P uniformly labeled RNA was mixed with 10 µl P3000 reagent in 250 µl Opti-MEM medium and 15 µl Lipofectamine 3000 was diluted in 250 µl Opti-MEM medium (Thermo Fisher Scientific). The two solutions were mixed and incubated at room temperature for 15 min followed by addition of 3.5 ml Opti-MEM to the RNA-Lipofectamine 3000 complexes and applied to the cell culture plates for 30 min. The cells were washed with Opti-MEM and removed from the dish. Untransfected RNAs were degraded by micrococcal nuclease (New England BioLabs) in the presence of 5 mM CaCl 2 for 30 min at 37 o C. The transfected cells were equally aliquoted into 60 mm cell culture plates and cultured at 37 o C. Cells were collected at 0, 1, 2 and 4 h time points after micrococcal nuclease treatment. Total RNA was isolated with TRIzol reagent and equal amounts of total RNA from the different time points were fractionated by 8% polyacrylamide gel with 7 M urea. The remaining 32 P-labeled RNA was analyzed by PhosphorImager.
RNA-Seq analysis. RNA was prepared, enriched by NAD-capture and sequenced as described 7 . Sequences were aligned with human hg19 genome (GRCh37) using the UCSC reference transcript map using Tophat 41 and the resulting binary sequence alignment/map format files were sorted, duplicates were removed using Picard (Broad Institute; http://broadinstitute.github.io/picard), and transcripts were quantified using Cuffdiff 41 . Results were exported to the CummeRbund package 41 in R/Bioconductor. Only transcripts with expression levels of FPKM greater than 1.0 in the knockout condition were considered to be detectable. Sequencing data have been deposited in the Gene Expression Omnibus (GEO) database (accession nos. GSE90884 (DXO-KO) and GSE110801 (N12-KO)).
Protein expression, purification and crystallization. NudC recombinant protein was kindly provided by Bryce Nickels (Waksman Institute of Microbiology, Rutgers University). Nudt12, Nudt13 and RppH recombinant proteins carrying an N-terminal His-tag were expressed from plasmids pET28a-Nudt12, pET28a-Nudt13 and pET28a-RppH described previously 21 .
Residues 126-462 of wild-type mouse Nudt12 were sub-cloned into the pET28a vector (Novagen), and the recombinant protein contained an N-terminal His-tag. This purified wild-type protein did not produce any crystallization hits. The E219A/E220A/E221A triple mutation was introduced using the transfer-PCR method 42 . The mutant protein was expressed in E. coli BL21(DE3) Star cells at 20 °C for 18 h. The cells were lysed by sonication in a buffer containing 20 mM Tris (pH 8.0), 250 mM NaCl and 5% (v/v) glycerol. The lysate was loaded onto an Ni-NTA (Qiagen) column. The eluted protein was treated overnight with thrombin at 4 °C to remove the His-tag and was further purified by gel filtration chromatography (Sephacryl S-300; GE Healthcare). The purified protein was concentrated to 23 mg ml −1 in a solution containing 20 mM Tris (pH 8.0), 200 mM NaCl and 5 mM DTT before being flash-frozen in liquid nitrogen and stored at -80 °C.
For crystallization, the above triple mutate protein at 8 mg ml −1 concentration was incubated with 1.5 mM NAD (Sigma) in a buffer containing 20 mM Tris (pH 8.0), 200 mM NaCl, 5 mM DTT and 2 mM MgCl 2 at 4 °C for 30 min. Crystals were obtained at 20 °C using the sitting-drop vapor-diffusion method. The reservoir solution contained 0.1 M HEPES (pH 7.5) and 24% (w/v) PEG2000MME. The crystals were cryo-protected by the reservoir solution supplemented with 15% (v/v) ethylene glycol and were flash-frozen in liquid nitrogen for data collection at 100 K.
Data collection and structure determination. X-ray diffraction data were collected using the Pilatus-6M detector at the Advanced Photon Source beamline 24-ID-C. The X-ray wavelength was 0.9791 Å. The diffraction images were processed and scaled using the XDS program 43 . The crystal belonged to space group P1 with unit cell dimensions of a = 56.2 Å, b = 58.6 Å and c = 61.7 Å. There is a Nudt12 homodimer in the crystallographic asymmetric unit.
The catalytic domain of Nudt12 shares 29% sequence identity with NudC, and a molecular replacement solution could readily be found using the structure of NudC as the search model 24 with the program Phaser 44 . However, the resulting electron density map was not of sufficient quality to rebuild the model. To obtain separate phase information, the CTD of Nudt12 was located using the molecular replacement method. The phase information from this model was used to calculate an anomalous difference electron density map, which clearly revealed the positions of the two zinc atoms (with 11α peak heights), even though the diffraction data were collected far above the zinc absorption edge. Phase information from anomalous scattering was combined with that from the model, and the CTD could be rebuilt automatically using the resulting map with PHENIX 45 . Several β-strands in the NTD and segments near the zinc could be built manually with the program Coot 46 and were included in the subsequent structure refinement with PHENIX, which led to an improved 2F o -F c map. The entire structure was obtained after several rounds of manual model building followed by refinement. In the final model, 98.7% of the residues are in the favored region of the Ramachandran plot, and 0.16% (one residue) is located just outside the allowed region. The crystallographic information is summarized in Supplementary Table 1. RNA isolation, reverse transcription and real-time RT-qPCR. Total cellular RNA was collected with TRIzol reagent (Thermo Fisher Scientific) and treated with DNase (Promega) according to the manufacturers' protocols. Reverse transcription was performed on 2 μg of RNA in 20-μl reaction mixtures with M-MLV reverse transcriptase, random hexamers and oligo(dT) (Promega) according to the manufacturer's instructions. qRT-PCR was performed with the primers listed in a Supplementary Table 4 . qRT-PCR was carried out on Rotor-Gene 3000 (Corbett Research) with iTaq SYBR Green Supermix (Bio-Rad Laboratories). Relative mRNA levels were normalized to 18S rRNA and calculated as described in User Bulletin No. 2 for the ABI Prism 7700 Sequence Detection System. NAD-capQ. HEK293T cells (6 × 10 6 ) were seeded in 100 mm plates a day before the experiment and cells were collected for protein or RNA extraction at ~80% confluency. NAD-capQ was carried out as described 18 . To measure NAD-cap amounts on RNA, total cellular RNA was extracted with TRIzol reagent according to the manufacturer's protocol (Thermo Fisher Scientific). To maximize removal of potential residual free NAD copurifying with the RNA, isolated RNA was dissolved in 10 mM Tris-HCl (pH 7.5) containing 2 M urea. Samples were incubated 2 min at 65 °C and immediately precipitated with isopropanol in the presence of 2 M (final concentration) ammonium acetate. Fifty micrograms of total RNA was subjected to NAD-capQ assay as described 18 . Briefly, total RNA was digested with 1 U of Nuclease P1 (Sigma-Aldrich) in 20 μl of 10 mM Tris (pH 7.0), 20 μM ZnCl 2 at 37 °C for 20 min to release 5′ end NAD. The control samples were prepared by incubating 50 μg of RNA treated with the same reaction condition including 10% glycerol used to dissolve the enzyme, but lacked Nuclease P1. After the reaction, 30 μl of NAD/NADH Extraction Buffer (NAD/NADH Quantitation Kit, Sigma-Aldrich) was added to each sample. In the second step, 50 μl samples were used to perform the colorimetric assay according to the manufacturer's protocol (NAD/NADH Quantitation Kit, Sigma-Aldrich).
Cellular total NAD quantitation. HEK293T cells (6 × 10 6 ) were seeded in 100 mm plates a day before the experiment. Cells were ~80% confluent at the time of protein extraction. To measure cellular total NAD levels, one-fifth of the cells were lysed in 400 μl of NAD/NADH Extraction Buffer (NAD/NADH Quantitation Kit, Sigma-Aldrich) and total protein was extracted by two freeze/thaw cycles (20 min on dry ice, then 15 min at room temperature). Cell lysates were centrifuged at 13,000g at 4 °C for 10 min and supernatant was taken to measure protein concentration. 10 μg of total proteins were used to detect cellular NAD according to the manufacturer's protocol (NAD/NADH Quantitation Kit, Sigma).
Western blot analysis. Cells were lysed in phosphate-buffered saline containing 0.5% IGEPAL CA-630 (Sigma-Aldrich), protease inhibitors (Roche Applied Science) and sonicated. Equal protein amounts of the different samples were separated by Bolt 4-12% Bis-Tris Plus Gel (Thermo Fisher Scientific) and transferred to nitrocellulose membranes (Bio-Rad). The blots were incubated with primary antibodies in phosphate-buffered saline buffer supplemented with 5% BSA (Sigma-Aldrich), then with secondary antibodies conjugated to horseradish peroxidase. Proteins were detected using the ECL western blotting substrate (Thermo Fisher Scientific). The following antibodies were used in this study: rabbit polyclonal anti-DXO (Dom3Z) (Proteintech, catalog no. 11015-2-AP); rabbit polyclonal anti-Nudt12 (Abcam, catalog no. ab197310); mouse monoclonal anti-glyceraldehyde 3-phosphate dehydrogenase (Sigma-Aldrich, catalog no. G8795) and mouse monoclonal anti-β-tubulin (Sigma-Aldrich, catalog no. T8328).
Quantification and statistical analysis. mRNA half-lives of reporter mRNAs were obtained by constructing linear models of the ln(remaining RNA) as a function of time and then the half-life was calculated as the ln(2)/slope (ref. 47 ). All data are presented at the ±95% confidence interval and P values were calculated from the linear model using R 48, 49 . Following alignment with genome sequences, sequencing reads were assembled with the UCSC hg19 reference transcript map using Cufflinks, allowing a direct comparison of expression levels by Cuffdiff. Results were exported to the CummeRbund package 41 in R/Bioconductor 48, 49 . Only transcripts with expression levels of FPKM greater than 1.0 in at least one condition were considered to be expressed.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request. Sequencing data have been deposited in the Gene Expression Omnibus (GEO) database (accession nos. GSE90884 (DXO-KO) and GSE110801 (N12-KO)). The atomic coordinates have been deposited at the Protein Data Bank (PDB entry 6O3P).
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